Latest Blogs, Articles, and More View More >>
FDA Approval Sought for New Treatment of NSCLC Subset
BY SILAS INMAN
Rolling submission of a new drug application for rociletinib has been initiated for patients with EGFR T790M-positive metastatic NSCLC following prior treatment with an EGFR-targeted therapy.
Are You a Connected Cancer Patient? Tell the President’s Cancer Panel What You Think!
BY JANET FREEMAN-DAILY
The President's Cancer Panel is looking for ways to improve connected health for cancer patients. What are your recommendations?
A Ceiling on Healing?
BY KHEVIN BARNES
Living on the top floor with cancer.
An Introduction From a Two-Time Cancer Survivor
BY BARBARA TAKO
Breast cancer and melanoma survivor Barbara Tako introduces herself.
The Sweet Truth
BY JESSICA IANNOTTA
Does sugar cause cancer? Does sugar feed cancer?
Pregnancy and a Breast Cancer Diagnosis
BY ELEANOR MILLER
Eleanor Miller, a nurse at the University of Pennsylvania, writes about considerations for a patient who is pregnant with a breast cancer diagnosis.
IV Emend Helps Prevent CINV With Moderately Emetogenic Chemotherapy
BY LAUREN M. GREEN
A single intravenous dose of EMEND for Injection was shown to be superior to placebo when either were combined with other anti-vomiting agents for protection against CINV in patients receiving moderately emetogenic chemotherapy.
Special Feature
ShareYourStory
$auto_registration$